Ocular adnexal IgG4-related lymphoplasmacytic infiltrative disorder and graves ophthalmopathy

Archives of Ophthalmology

Volumn 129, Issue 6, 2011, Pages 818-819

  Kubota, Toshinobu ^a   Moritani, Suzuko ^a   Terasaki, Hiroko ^b  

^a NATIONAL HOSPITAL ORGANIZATION NAGOYA MEDICAL CENTER   (Japan)

^b NAGOYA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G4; PREDNISOLONE; THYROID PEROXIDASE ANTIBODY; THYROID STIMULATING HORMONE RECEPTOR ANTIBODY; THYROID STIMULATING IMMUNOGLOBULIN; UNCLASSIFIED DRUG;

ADULT; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; DISEASE ASSOCIATION; ENDOCRINE OPHTHALMOPATHY; EYELID TUMOR; FEMALE; HELPER CELL; HISTOPATHOLOGY; HUMAN; HYPERTHYROIDISM; IDIOPATHIC ORBITAL INFLAMMATION; IMMUNOGLOBULIN BLOOD LEVEL; LETTER; LYMPHOPROLIFERATIVE DISEASE; OCULAR ADNEXAL IGG4 RELATED LYMPHOPLASMACYTIC INFILTRATIVE DISORDER; ORBIT DISEASE; PALPATION; PATHOPHYSIOLOGY; PATIENT REFERRAL; PLASMA CELL; PRIORITY JOURNAL; SEROLOGY;

ANTIBODIES, ANTI-IDIOTYPIC; DIAGNOSIS, DIFFERENTIAL; EYELID NEOPLASMS; FEMALE; GRAVES OPHTHALMOPATHY; HUMANS; IMMUNOGLOBULIN G; MIDDLE AGED; WALDENSTROM MACROGLOBULINEMIA;

EID: 79958729771     PISSN: 00039950     EISSN: 15383601     Source Type: Journal    
DOI: 10.1001/archophthalmol.2011.138     Document Type: Letter

References (4)

1. Bijlsma WR, Kalmann R. Idiopathic orbital inflammation and Graves ophthalmopathy. Arch Ophthalmol. 2010;128(1):131-132.
2. Kubota T, Moritani S, Katayama M, Terasaki H. Ocular adnexal IgG4-related lymphoplasmacytic infiltrative disorder. Arch Ophthalmol. 2010;128(5):577-584.
3. Kallmann BA, Hüther M, Tubes M, et al. Systemic bias of cytokine production toward cell-mediated immune regulation in IDDM and toward humoral immunity in Graves' disease. Diabetes. 1997;46(2):237-243. (Pubitemid 27272257)
4. Mullins RJ, Cohen SB, Webb LM, et al. Identification of thyroid stimulating hormone receptor-specific T cells in Graves' disease thyroid using autoantigen-transfected Epstein-Barr virus-transformed B cell lines. J Clin Invest. 1995;96(1):30-37.